PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm

Bridging the ADMET Translational Gap: How New Approach Methodologies and Organ-on-a-Chip Technology Are Redefining Drug Development

Drug developers face challenges in translating preclinical findings to safe and effective human trials. Traditionally,
preclinical testing relies on a phased approach that combines simple in vitro assays and whole animal in vivo studies; however, a translational gap remains between these findings and the clinical outcomes.

The translational gap is caused by the limited ability of simple in vitro assays to accurately predict human responses, combined with the interspecies limitations of animal studies, a core requirement by global regulatory
bodies before human trials, unless no suitable model exists. The transition from preclinical models to human subjects therefore requires navigating complex pharmacokinetic (PK) and toxicology uncertainties that vary significantly by drug modality and therapeutic area.

Our inability to adequately address these uncertainties is represented by consistently high drug attrition rates. Toxicity remains one of the most significant causes of drug attrition, accounting for 30% of drug failures in the clinic.1 Poor human translation in pre-clinical PK studies is also a major driver of clinical failures, with PK and bioavailability listed as the third most common cause of attrition and 16% of all failures.2

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC